Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.
Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, Cendrillon R, Cusack MP, Demiralp E, Jooste SK, Kharbouch A, Lee AA, Lehár J, Liu M, Mahadevan S, Murphy M, Norton LC, Parlikar TA, Pathak A, Shoeb A, Soderberg E, Stephens P, Stoertz AH, Thng F, Tumkur K, Wang H, Rhodes J, Rudick RA, Ransohoff RM, Phillips GA, Bruzik E, Marks WJ, Weiner HL, Snyder TM.
Chitnis T, et al. Among authors: diaz cruz c.
NPJ Digit Med. 2019 Dec 11;2:123. doi: 10.1038/s41746-019-0197-7. eCollection 2019.
NPJ Digit Med. 2019.
PMID: 31840094
Free PMC article.